Glycosaminoglycans having an average molecular weight of 2400 D suitable for the treatment of senile dementia
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 27, 2005
Grant Date -
N/A
app pub date -
May 12, 2000
filing date -
May 14, 1999
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to the use of glycosaminoglycans having an average/molecular weight of 2,400 D for the preparation of pharmaceutical compositions suitable for the treatment of senile dementia, in particular for the treatment of Alzheimer's disease or SDAT (Senile Dementia Alzheimer's Type) and of the cerebral neurological lesions from ictus and from traumas.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully